Hydrocodone Extended-Release Tablets and Perflutren lipid microsphere Intravenous
Determining the interaction of Hydrocodone Extended-Release Tablets and Perflutren lipid microsphere Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: hydrocodone
Brand name: Hysingla ER, Zohydro ER, Vantrela ER
Synonyms: Hydrocodone
Generic Name: perflutren
Brand name: Definity, Optison
Synonyms: Perflutren, Perflutren Lipid Microspheres
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hydrocodone Extended-Release Tablets-Perflutren Lipid Microspheres
- Hydrocodone Extended-Release Tablets-Perflutren Protein Type A
- Hydrocodone Extended-Release Tablets-Perflutren protein type a microsphere Intravenous
- Hydrocodone Extended-Release Tablets-Perforomist
- Hydrocodone Extended-Release Tablets-Perforomist, Symbicort
- Hydrocodone Extended-Release Tablets-Pergolide
- Perflutren lipid microsphere Intravenous-Hydrocodone Polistirex and Chlorpheniramine Polistirex Suspension
- Perflutren lipid microsphere Intravenous-Hydrocodone, Chlorpheniramine, and Pseudoephedrine
- Perflutren lipid microsphere Intravenous-Hydrocodone, Pseudoephedrine, and Guaifenesin
- Perflutren lipid microsphere Intravenous-Hydrocortisone
- Perflutren lipid microsphere Intravenous-Hydrocortisone (Systemic)
- Perflutren lipid microsphere Intravenous-Hydrocortisone 2.5%